(Press-News.org) Other important data the European IVF Monitoring group (EIM) on 2008 cycles and the International Committee Monitoring Assisted Reproductive Technologies (ICMART) on 2007 cycles highlighted were Sweden's low rate of multiple births – the lowest in the world – and Spain's 30 % share of egg donations in Europe.
The EIM collected data on frozen oocyte retrieval (FOR) cycles for the first time. Until today, egg freezing is still not offered on a wide scale but can be an option for women who wish to postpone motherhood or are facing cancer therapy to save their lives. Recently, vitrification techniques have offered oocyte survival rates in excess of 90 % and implantation rates per transfer that are comparable with fresh eggs. Scientists still face problems such as poor oocyte survival post-thaw, low fertilisation rates, cytoskeletal damage during vitrification and poor reproducibility of results.
"Of the 19 countries reporting on FOR in 2008, Italy is by far the country with the most cycles using this technology," said Dr. Jacques de Mouzon, chair of the EIM. With 3,284 cycles, Italy is far ahead of Finland (325 cycles), Russia (220) and Spain (199). The reason for Italy's dominance in this area lies in its legislative framework. A law passed in 2004 and overruled in 2009, set a limit of three oocytes to be inseminated per cycle, of which all resulting embryos had to be transferred. Embryo freezing and research on the embryo was outlawed, but not egg freezing. Hence, Italian clinics gained considerable expertise in this area over the last years.
The group also reported that with 4,068 cycles, 30 % of all egg donations (ED) occur in Spain, followed by the Czech Republic (15 %) and Russia (12 %). "Three countries make up almost 60 % of all egg donations in Europe," said Dr. De Mouzon. "Certain clinics in Spain offer wide-ranging egg donation programmes, which may also be the reason why Spain scores so high in terms of frozen oocyte cycles." This fact is mostly due to restrictive laws on ED in many countries, leading to many couples to cross borders to countries with less restrictive laws, which has raised an ethical and public health problem.
During the same scientific session, Dr. Karl Nygren, chair of ICMART, presented global ART data for 2007. "We are particularly pleased to present our data in Stockholm this year, since we can show that Sweden, a pioneer in enforcing single embryo transfer, has the world's lowest multiple birth rate with only 7 % twins and 0.1% of triplets being born after IVF and ICSI." Only Finland and Australia show comparably low rates with 9.3 % and 8.4% of twins, respectively, and almost no triplets. Many countries are still above 20 % for twin deliveries following IVF or ICSI such as for example Spain (23.8 %), Italy (21.2 %) and Germany (21.1 %) as are many Eastern European countries. "We would like to see more countries follow suit to decrease long-term complications for mother and child." The average rate in Europe was 20.6 % for twins and 1.1% for triplets in Europe.
According to data presented by the European IVF Monitoring Group (EIM), 525,640 treatment cycles were reported in 36 European countries. Four more countries reported in 2008 compared to 2007. This compares globally with 148,055 cycles from the US and 61,929 cycles from Australia and New Zealand. "We observed a 9.7 % increase in the number of cycles in Europe from 2007 to 2008, with only 21 more clinics reporting to our database," said Dr. Jacques de Mouzon, chairman of ESHRE's EIM. The delivery rate (DR) per aspiration was 22.1% for IVF and 21.1% for ICSI. DR per transfer was 14.5% for FET and 28.5% for ED. All these rates were relatively stable compared to the previous year, as was the multiple deliveries proportion.
In 30 countries where clinics reported deliveries, 80,284 babies were born. "We believe this to be an underestimate since data on deliveries for Turkey, Poland and some other countries were still missing." There were 124,749 IVF treatments, 280,977 intracytoplasmic sperm injection (ICSI) cycles, 98,288 frozen embryo transfer cycles (FER), 13,609 egg donor cycles (ED), 4,080 FOR, 2,875 preimplantation genetic diagnosis/screening cycles (PGD/PGS) and 1,062 in vitro maturation cycles (IVM).
In terms of ART availability, the largest economies in Europe such as France (5,464 cycles per million women of reproductive age), Italy (4,015), Spain (3,845), the Netherlands (6,382), Germany (4,810) and the UK (4,066) still show much lower availabilities of ART compared to their Nordic neighbours such as Sweden (9,228), Norway (9,287), Denmark (12,712) and Finland (9,291). This is also mirrored in the number of infants born after ART with only 1.7 % in Spain, 2.4 % in the Netherlands, 1.4 % in Germany and 1.9 % in the UK compared to 3.3 % in Sweden, 2.4 % in Norway and 3.0 % in Finland. For Denmark figures were not available yet. Also, 25 countries reported 146,741 IUI-H (with husband's sperm) and 24, 895 IUI-D (donor sperm), with a multiple pregnancy rate (11.1% twin and 0.8 triplet for women aged less than 40 years) not higher than in IVF and ICSI.
###
U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), Assisted Reproduction Technology Success Rates, National Summary and Fertility Clinic Reports, December 2010 at http://www.cdc.gov/art/ART2008/PDF/ART_2008_Full.pdf
AIHW (2010) Australian Institute of Health and Welfare, Assisted Reproduction Technology in Australia and New Zealand 2008. National Perinatal Statistical Unit and Fertility Society of Australia. Assisted Reproduction Technology Series, number 14, at http://www.aihw.gov.au/publication-detail/?id=6442468391&tab=2
Full pdfs of these references are available on request.
Abstract no: Dr. De Mouzon O-208 Wednesday 6 July 2011, 8.30 hrs CEST (Hall A1)
Dr. Nygren O-209 Wednesday 6 July 2011, 8.50 hrs CEST (Hall A1)
Note: When obtaining outside comment, journalists are requested to ensure that their contacts are aware of the embargo on this release.
For further information on the details contained in this press release, contact:
In English, German, Spanish, French
Hanna Hanssen
Tel: +32 (0) 263 64 66
Mobile: + 32 (0) 473 35 33 81
Email: hanna@eshre.eu
For the first time, the European IVF Monitoring Group reports on cycles using frozen eggs
2011-07-07
ELSE PRESS RELEASES FROM THIS DATE:
The long-term fiscal impact of funding cuts for IVF in Denmark
2011-07-07
In 2009, 1,547 ART children were born in public clinics in Denmark, projecting a net tax revenue of €224 million and €247 million in 25 and 50 years respectively. The authors of the study calculated that reductions of 30-50% in ART cycles following the new policy would lead to cost savings of €67 - €111 million for the Danish government in 2034. By 2059 however, when the IVF cohort are 50 years of age, the government would have lost €74 - €123 million due to less tax contributions from fewer children born.
"The most common argument governments use not to fund ART is ...
Socioeconomic class and smoking linked to premature menopause
2011-07-07
POF is not only associated with infertility but also with significantly increased morbidity and mortality, as well as a decreased quality of life equivalent to that of people with type 2 diabetes or rheumatoid arthritis, said Dr. Rumana Islam, from Imperial College, London, UK.
Previous studies of POF, defined as the onset of menopause before the age of 40, have assessed the small group of women who seek hospital care, and therefore there is little information about the risks and impacts of POF across a whole population, Dr. Islam explained. With her colleague Dr. Rufus ...
Worldwide study identifies top global challenges in mental health
2011-07-07
TORONTO, ON – A Toronto-based researcher is at the helm of a massive, worldwide study that identifies the top global challenges in mental health. The paper resulting from the study appears in Nature today.
Professor Abdallah S. Daar, senior scientist with the McLaughlin-Rotman Centre for Global Health at the University Health Network (UHN) and the University of Toronto, co-authored the historic study, "Grand Challenges in Global Mental Health." The study – the world's largest of its kind – brought together more than 400 international researchers, advocates, clinicians ...
Discovery of why sunburn hurts could lead to new pain relief for inflammatory conditions
2011-07-07
Researchers at King's College London have found a molecule in the body which controls sensitivity to pain from UVB irradiation, identifying it as a new target for medicines to treat pain caused by other common inflammatory conditions such as arthritis.
The molecule, called CXCL5, is part of a family of proteins called chemokines, which recruit inflammatory immune cells to the injured tissue, triggering pain and tenderness. This is the first study to reveal this molecule's role in mediating pain.
The study, funded by the Wellcome Trust (as part of the London Pain Consortium), ...
Hydrogen peroxide found in space
2011-07-07
An international team of astronomers made the discovery with the Atacama Pathfinder Experiment telescope (APEX), situated on the 5000-metre-high Chajnantor plateau in the Chilean Andes. They observed a region in our galaxy close to the star Rho Ophiuchi, about 400 light-years away. The region contains very cold (around -250 degrees Celsius), dense clouds of cosmic gas and dust, in which new stars are being born. The clouds are mostly made of hydrogen, but contain traces of other chemicals, and are prime targets for astronomers hunting for molecules in space. Telescopes ...
Beauty is in the medial orbito-frontal cortex of the beholder, study finds
2011-07-07
A region at the front of the brain 'lights up' when we experience beauty in a piece of art or a musical excerpt, according to new research funded by the Wellcome Trust. The study, published today in the open access journal PLoS One, suggests that the one characteristic that all works of art, whatever their nature, have in common is that they lead to activity in that same region of the brain, and goes some way to supporting the views of David Hume and others that beauty lies in the beholder rather than in the object.
"The question of whether there are characteristics that ...
Chips hold the key to understanding the human brain
2011-07-07
Chips based on ARM processor technology will be linked together to simulate the highly-complex workings of the brain, whose functionality derives from networks of billions of interacting, highly-connected neurons.
The chips upon which this work critically depends were delivered last month, and have passed their functionality tests with flying colours.
They will form the system architecture for a massive computer, called SpiNNaker (Spiking Neural Network architecture), which aims to map out the brain's individual functions.
SpiNNaker could be a vital tool for neuroscientists, ...
Thinking globally to improve mental health
2011-07-07
Mental health experts are calling for a greater world focus on improving access to care and treatment for mental, neurological, and substance use (MNS) disorders, as well as increasing discoveries in research that will enable this goal to be met.
The Grand Challenges in Global Mental Health Initiative, led by the National Institutes of Health and the Global Alliance for Chronic Diseases, has identified the top 40 barriers to better mental health around the world. Similar to past grand challenges, which focused on infectious diseases and chronic, noncommunicable diseases, ...
Pixel perfect: Cornell develops a lens-free, pinhead-size camera
2011-07-07
ITHACA, N.Y. – It's like a Brownie camera for the digital age: The microscopic device fits on the head of a pin, contains no lenses or moving parts, costs pennies to make – and this Cornell-developed camera could revolutionize an array of science from surgery to robotics.
The camera was invented in the lab of Alyosha Molnar, Cornell assistant professor of electrical and computer engineering, and developed by a group led by Patrick Gill, a postdoctoral associate. Their working prototype, detailed online in the journal Optics Letters (July 6, 2011), is 100th of a millimeter ...
First whole-genome lung cancer study by TGen and Virginia G. Piper Cancer Center set for conference
2011-07-07
PHOENIX, Ariz. — July 6, 2011 — A first-of-its-kind study of a patient with lung cancer who never smoked will be presented today by TGen and the Virginia G. Piper Cancer Center at Scottsdale Healthcare at the 14th World Conference on Lung Cancer, July 3-7 in Amsterdam.
Researchers for the first time sequenced the entire DNA and RNA of a patient with metastatic adenocarcinoma of the lung, said Dr. Glen Weiss, the first author of the study, which will be published in a special supplement of the Journal of Thoracic Oncology. Dr. Weiss also is Director of Thoracic Oncology ...